Kathryn J. Collier

Kathryn J. Collier appears in our data through filings on Regulus Therapeutics Inc. shares, published by SEC (Form 4). We count 10 filings; the first trade dates from 14 April 2018 and the latest from 25 June 2025.

No open-market sale appears; the market trades are 2 purchases worth €16k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants and 3 option exercises.

On 27 June 2025 came the latest disclosure, a transaction in Regulus Therapeutics Inc. The clock since the last published purchase (29 July 2024) now reads 817 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.